Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Versus Twice-Daily Ramipril Dosing in CKD and HFrEF
NCT07259512Phase 4Recruiting
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramipril in chronic kidney disease (CKD), heart failure with reduced ejection fraction (HFrEF). Started Jun 2025; status: recruiting.
02
Drugs
ramipril
03
Conditions
chronic kidney disease (CKD)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT07259512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07259512.